Atlas Trials

Cutaneous T Cell Lymphoma (CTCL)

23 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Cutaneous T Cell Lymphoma (CTCL)

RecordFirmDate
Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors (NCT05225584)Kymera Therapeutics, Inc.2022-05-19
A Phase 1/2a Study of CDK-003 in Patients With Cutaneous T-Cell Lymphoma (CTCL). (NCT05156229)Codiak BioSciences2021-09-06
A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies (NCT04072458)Bio-Path Holdings, Inc.2020-11-05
A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma (NCT02616965)Fox Chase Cancer Center2017-02-22
Subcutaneous Recombinant Human IL-15 (s.c. rhIL-15) and Alemtuzumab for People With Refractory or Relapsed Chronic and Acute Adult T-cell Leukemia (ATL) (NCT02689453)National Cancer Institute (NCI)2017-01-19
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL (NCT02580552)miRagen Therapeutics, Inc.2016-02-09
NM-IL-12 in Cutaneous T-Cell Lymphoma (CTCL) Undergoing Total Skin Electron Beam Therapy (TSEBT) (NCT02542124)Neumedicines Inc.2015-12-01
Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma (NCT02213861)TetraLogic Pharmaceuticals2014-11-01
Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL) (NCT01843998)Stefan Schieke MD2014-02-01
Brentuximab Vedotin (SGN-35) in Patients With Mycosis Fungoides With Variable CD30 Expression Level (NCT01396070)Youn Kim2011-05-01
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment (NCT01087333)National Cancer Institute (NCI)2010-03-02
A-dmDT390-bisFv(UCHT1) Immunotoxin Therapy for Patients With Cutaneous T-Cell Lymphoma (CTCL) (NCT00611208)Virogen Biotechnology Inc.2008-01-01
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma (NCT00501735)BioCryst Pharmaceuticals2007-07-01
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma (NCT00476554)Cyclacel Pharmaceuticals, Inc.2007-04-01

Track Cutaneous T Cell Lymphoma (CTCL) automatically

Every clearance here is in the API, with alerts when new ones post.